476 related articles for article (PubMed ID: 27226613)
21. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
[TBL] [Abstract][Full Text] [Related]
22. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD).
Lee JJ; Park JK; Jeong J; Jeon H; Yoon JB; Kim EE; Lee KJ
J Biol Chem; 2013 Mar; 288(10):6998-7011. PubMed ID: 23293021
[TBL] [Abstract][Full Text] [Related]
23. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
[TBL] [Abstract][Full Text] [Related]
24. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
Kobayashi T; Tanaka K; Inoue K; Kakizuka A
J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
[TBL] [Abstract][Full Text] [Related]
25. Pro178 and Pro183 of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation.
Lee JH; Kwon JH; Jeon YH; Ko KY; Lee SR; Kim IY
J Biol Chem; 2014 May; 289(20):13758-68. PubMed ID: 24700463
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
27. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease.
Ju JS; Miller SE; Hanson PI; Weihl CC
J Biol Chem; 2008 Oct; 283(44):30289-99. PubMed ID: 18715868
[TBL] [Abstract][Full Text] [Related]
28. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
29. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis.
Meyer H; Weihl CC
J Cell Sci; 2014 Sep; 127(Pt 18):3877-83. PubMed ID: 25146396
[TBL] [Abstract][Full Text] [Related]
30. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
[TBL] [Abstract][Full Text] [Related]
31. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
[TBL] [Abstract][Full Text] [Related]
32. Altered cofactor regulation with disease-associated p97/VCP mutations.
Zhang X; Gui L; Zhang X; Bulfer SL; Sanghez V; Wong DE; Lee Y; Lehmann L; Lee JS; Shih PY; Lin HJ; Iacovino M; Weihl CC; Arkin MR; Wang Y; Chou TF
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1705-14. PubMed ID: 25775548
[TBL] [Abstract][Full Text] [Related]
33. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
34. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
Vij N
J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
[TBL] [Abstract][Full Text] [Related]
35. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
36. Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration.
Poksay KS; Madden DT; Peter AK; Niazi K; Banwait S; Crippen D; Bredesen DE; Rao RV
J Mol Neurosci; 2011 Jun; 44(2):91-102. PubMed ID: 21249466
[TBL] [Abstract][Full Text] [Related]
37. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
Gitcho MA; Strider J; Carter D; Taylor-Reinwald L; Forman MS; Goate AM; Cairns NJ
J Biol Chem; 2009 May; 284(18):12384-98. PubMed ID: 19237541
[TBL] [Abstract][Full Text] [Related]
38. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
Manno A; Noguchi M; Fukushi J; Motohashi Y; Kakizuka A
Genes Cells; 2010 Aug; 15(8):911-22. PubMed ID: 20604808
[TBL] [Abstract][Full Text] [Related]
39. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells.
Ferrari V; Cristofani R; Cicardi ME; Tedesco B; Crippa V; Chierichetti M; Casarotto E; Cozzi M; Mina F; Galbiati M; Piccolella M; Carra S; Vaccari T; Nalbandian A; Kimonis V; Fortuna TR; Pandey UB; Gagliani MC; Cortese K; Rusmini P; Poletti A
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12818. PubMed ID: 35501124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
